Epidemiological studies have revealed a high prevalence of sleep-disordered breathing in
the community (up to 20%). A subset of these patients has concurrent symptoms of excessive …

Melatonin is a physiological hormone involved in sleep timing and is currently used exogenously
in the treatment of primary and secondary sleep disorders with empirical evidence of …

Obstructive sleep apnoea (OSA) and obstructive sleep apnoea/hypopnoea syndrome (OSAHS)
have long been considered predominantly male-related conditions. The clinical …

Background Isolated rapid-eye-movement (REM) sleep behaviour disorder (IRBD) can be
part of the prodromal stage of the α-synucleinopathies Parkinson's disease and dementia with …

Background The therapeutic and economic benefits of continuous positive airway pressure (CPAP)
for moderate to severe obstructive sleep apnoea (OSA) syndrome have been …

Snoring is common in pregnancy, and snoring pregnant women have increased rates of pre-eclampsia.
Patients with pre-eclampsia show upper airway narrowing during sleep. The …

Background Clinical presentation phenotypes of obstructive sleep apnoea (OSA) and their
association with comorbidity as well as impact on adherence to continuous positive airway …

Polygraphy ( PG ) and polysomnography ( PSG ) are used in clinical settings in Europe for
diagnosing obstructive sleep apnea ( OSA ), but their equivalence in unselected clinical …

… Cephalometry in Sibs With and Without OSAHS—Riha et al … Riha, Brander, and Vennelle
have indicated no financial … Cephalometry in Sibs With and Without OSAHS—Riha et al …

Patients with obstructive sleep apnoea–hypopnoea syndrome (OSAHS) have elevated
circulating levels of tumour necrosis factor (TNF)-α. The hypothesis in this study was that OSAHS …